James Barlow
Patrimonio netto: 57 600 $ in data 31/07/2026
Patrimonio netto: 57 600 $ in data 31/07/2026
James F.
Barlow is currently Director at Arcturus Therapeutics, Inc., Independent Director at Arcturus Therapeutics Ltd. since 2018, Independent Director at Arcturus Therapeutics Holdings, Inc. since 2018, Director at Nahs Holding, Inc. since 2018, and Vice President at Vicept Therapeutics, Inc. Former roles include Chief Accounting Officer, Senior VP & Controller at Allergan, Inc. from 2002 to 2015, Treasurer & Controller at Wynn's International, Inc. from 1990 to 2000, Vice President & Controller at Ford Equipment Leasing Co. from 1986 to 1990, Principal at Deloitte Haskins & Sells (US) in 1985, and Chief Financial Officer at Winco Enterprises, Inc. in 2001.
Education includes undergraduate and graduate degrees from Brigham Young University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 10.000 ( 0,04% ) | 57 600 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direttore/Membro del Consiglio | 27/05/2018 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Corporate Officer/Principal | - |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direttore/Membro del Consiglio | 27/05/2018 |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direttore/Membro del Consiglio | - |
Nahs Holding, Inc. | Direttore/Membro del Consiglio | 01/07/2018 |
| Società | Posizione | Fine |
|---|---|---|
| ALLERGAN, INC. | Comptroller/Controller/Auditor | 01/03/2015 |
Winco Enterprises, Inc.
Winco Enterprises, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and markets automotive & industrial chemical products | Direttore Finanziario/CFO | 01/08/2001 |
Wynn's International, Inc.
Wynn's International, Inc. Automotive AftermarketConsumer Durables Supplies automotive, industrial components and specialty chemical products | Comptroller/Controller/Auditor | 01/09/2000 |
Ford Equipment Leasing Co. | Comptroller/Controller/Auditor | 01/01/1990 |
| ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wynn's International, Inc.
Wynn's International, Inc. Automotive AftermarketConsumer Durables Supplies automotive, industrial components and specialty chemical products | Consumer Durables |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Winco Enterprises, Inc.
Winco Enterprises, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and markets automotive & industrial chemical products | Process Industries |
Ford Equipment Leasing Co. | |
Deloitte Haskins & Sells (US) | |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Nahs Holding, Inc. | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale